Where does Medical Diagnostic Laboratories, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medical Diagnostic Laboratories, LLC ranks #7,438 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medical Diagnostic Laboratories, LLC hold?

Medical Diagnostic Laboratories, LLC holds 44 US utility patents granted between 2015 and 2023, spanning 10 technology areas.

What is Medical Diagnostic Laboratories, LLC's Innovation Score?

Medical Diagnostic Laboratories, LLC has an Innovation Score of 34.6 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Medical Diagnostic Laboratories, LLC's patent grant rate increasing or decreasing?

Medical Diagnostic Laboratories, LLC's recent grant velocity is -81% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medical Diagnostic Laboratories, LLC's patents?

Medical Diagnostic Laboratories, LLC's patents average 9.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medical Diagnostic Laboratories, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Medical Diagnostic Laboratories, LLC

Q: What technology areas does Medical Diagnostic Laboratories, LLC focus on?

Medical Diagnostic Laboratories, LLC's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 25 patents, ranking #182 of 2,502 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 44 granted patents across 10 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medical ranks #7,438 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 10 technology areas.

#7,438
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.6/100): 9.1
avg claims per patent: -81%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7438 · US Corporation #7,438 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 44 grants
UPPER-Q #7,438/49,997
PHOTO-FINISH Mainspring Energy
CPC-FOCUS C12Q · 10 areas
INNOV-THIN 34.6/100
CLAIMS-PAR 9.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -81% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mainspring Energy, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medical’s 34.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (38%) Velocity 4.8 pts (14%) Breadth 11.2 pts (32%) Claim depth 5.5 pts (16%)

Qualcomm Incorporated · highest

85
Advanced Technology · near

35
Chyng Hong · near

35
Medical Diagnostic… · this assignee

35
Quixey · near

35
TMT Tapping… · near

35
3D Lighting… · lowest

7

What this shows Medical's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medical?

Each dot is one of Medical’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medical’s own 9.1 claims/patent is at or below the 14.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Medical vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medical's grants concentrate

Medical Diagnostic Laboratories, LLC is a focused PatentsView assignee: 10 CPC subclasses with 56.8% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2015 (12 grants) versus a trough of 1 in 2020. By volume, Medical sits between Mega Brands Inc. and Nice-systems Ltd..

Medical's three-year grant acceleration

Medical Diagnostic Laboratories, LLC shows 5 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mega Brands

44
MIE University

44
Mjnn

44
Mainspring Energy

44
Memory

44
Morgan State Univ…

44
N E Chemcat

44
Nice-systems

44
Medical Diagnosti… ◀

44

What this shows Medical holds 44 patents at rank #7,441, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medical

By rank, the assignees closest to #7,441 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Medical's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medical, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Medical ranks #182 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Quixey, Inc. 35 Chyng Hong Electronic Co., Ltd. 35 TMT Tapping Measuring Technology SÀRL 35 Advanced Technology Inc. 35

Medical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medical Diagnostic Laboratories, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	27.3%
2016	8	18.2%
2017	8	18.2%
2018	4	9.1%
2019	5	11.4%
2020	1	2.3%
2021	1	2.3%
2022	3	6.8%
2023	2	4.5%

Which technologies does Medical Diagnostic Laboratories, LLC patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 25

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 20

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 19

C07K - Peptides 16

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

C12Y - Enzymes 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

H04N - Pictorial Communication, e.g. Television 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medical Diagnostic Laboratories, LLC's patent record in context - here's where to go next.

Medical Diagnostic Laboratories, LLC's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 56.8% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #7,438 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medical Diagnostic Laboratories, LLC against Mega Brands Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.